Menu Search
Equities

McBride PLC

  • Add to watchlist
  • Add to portfolio
  • Add an alert
MCB:LSE

McBride PLC

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (GBX)156.00
  • Today's Change0.20 / 0.13%
  • Shares traded74.24k
  • 1 Year change+15.13%
  • Beta1.4682
Data delayed at least 20 minutes, as of Feb 11 2026 16:35 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Forecasts data is unavailable for this security.

Consensus recommendation

  • 20-Feb-25
  • 20-Nov-25
  • 18-Dec-25
  • 15-Jan-26
  • 05-Feb-26
Select bar for recommendation details.
Recommendations05-Feb-26
Buy2
Outperform1
Hold0
Sell0
Strong Sell0

Share price forecast in GBX

The 2 analysts offering 12 month price targets for McBride plc have a median target of 190.00, with a high estimate of 190.00 and a low estimate of 190.00. The median estimate represents a 21.95% increase from the last price of 155.80.
High22.0%190.00
Med22.0%190.00
Low22.0%190.00

Dividends in GBX

In 2025, McBride PLC reported a dividend of 0.03 GBP. The 4 analysts covering the company expect dividends of 0.03 GBP for the upcoming fiscal year, an increase of 6.67%.
Note: The percentage change is calculated using unrounded (raw) dividend values.
Div growth (TTM)--
More ▼

Earnings history & estimates in GBX

McBride plc reported annual 2025 earnings of 21.10 per share on Sep 17, 2025.
Average growth rate-2.76%
More ▼

Revenue history & estimates in GBP

McBride plc had revenues for the full year 2025 of 926.50m. This was 0.89% below the prior year's results.
Average growth rate+8.69%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.